Port Erin Biopharma Investments Ltd (PEBI)

 

Latest News

NAV & Investment in AgeX Therapeutics Inc.

RNS Number: 6320L Port Erin Biopharma Investments Ltd 20 July 2017 20 July 2017 Port Erin Biopharma Investments Limited (the "Company") Net Asset Value calculation to 30 June 2017 Investment in AgeX Therapeutics Inc. The unaudited Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2017 was 9.35 pence per share, including un-...

Redemption of Interest in Magna Biopharma Fund

RNS Number: 1834D Port Erin Biopharma Investments Ltd 25 April 2017 25 April 2017 Port Erin Biopharma Investments Limited ("Port Erin" or "the Company") Redemption of holding in the Magna Biopharma Income Fund The Company announces that it will redeem for cash its entire holding of 87,125.729 units in the Magna Biopharma Income Fund ("MBIF")...

Net Asset Value(s)

RNS Number: 2482C Port Erin Biopharma Investments Ltd 12 April 2017 12 April 2017 Port Erin Biopharma Investments Limited (the "Company") Net Asset Value calculation to 31 March 2017 Jim Mellon, Chairman, commented: - "The Net Asset Value ("NAV") calculation for the Company as at closing on 31 March 2017 was 10.56 pence per share, including un-inve...

Port Erin Biopharma swings to H1 pretax profit

Port Erin Biopharma has swung to an H1 pretax profit of 429,311, from a year-ago loss of 184,674. Chairman Jim Mellon sa...

All News

DateHeadlineSource
20-07-17NAV & Investment in AgeX Therapeutics Inc.RNS
25-04-17Redemption of Interest in Magna Biopharma FundRNS
12-04-17Net Asset Value(s)RNS
29-03-17Port Erin Biopharma swings to H1 pretax profitStockMarketWire
29-03-17Half-year ReportRNS
10-02-17Result of AGMRNS
12-01-17Net Asset Value(s)RNS
23-12-16Final Results and Notice of AGMRNS
22-12-16Port Erin gives loan to Diabetic Boot CoStockMarketWire
22-12-16Loan to the Diabetic Boot Company LtdRNS
12-10-16Net Asset Value(s)RNS
22-07-16Net Asset Value(s)RNS
29-04-16Net Asset Value calculation to 31 March 2016RNS
15-04-16Port Erin appoints nomad and joint brokerStockMarketWire
15-04-16Change of AdviserRNS
18-03-16Holding(s) in CompanyRNS
17-03-16Port Erin Biopharma widens H1 pretax lossStockMarketWire
17-03-16Interim Results for the six months to 31 Dec 2015RNS
10-02-16PEBI shareholders approve AGM resolutionsStockMarketWire
10-02-16Result of AGMRNS
25-01-16Net Asset Value(s)RNS
22-12-15Annual Audited Results and Notice of AGMRNS
17-12-15DBC receives US FDA approval to market PulseFlowDFRNS
04-11-15Net Asset Value(s)RNS
30-07-15Net Asset Value(s)RNS
15-04-15Net Asset Value as at 31 March 2015RNS
30-03-15Port Erin Biopharma swings to H1 pretax lossStockMarketWire
30-03-15Interim results for 6 months to 31 December 2014RNS
06-02-15Close of Tender OfferRNS
04-02-15Re Results of Tender OfferRNS
02-02-15Results of Tender OfferRNS
23-01-15Holding(s) in CompanyRNS
15-01-15Holding(s) in CompanyRNS
14-01-15Tender OfferRNS
12-01-15Net Asset ValueRNS
30-12-14FTSE falls as oils stocks slip on softening crudeStockMarketWire
30-12-14Port Erin Biopharma books FY pretax profitStockMarketWire
30-12-14Annual audited resultsRNS
23-12-14Holding(s) in CompanyRNS
28-11-14Tender Offer in respect of Magna BiopharmaRNS

RSS feeds

  • Editorial news feed for LSE:PEBI Editorial
  • Regulatory news feed for LSE:PEBI Regulatory